drugset / Trial / NCT00598078

Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

NCT00598078

Phase 2 Completed 19 enrolled Jazz Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

To determine the relationship between drug plasma levels and safety, tolerability and efficacy in patients with essential tremors after dosing with Sodium oxybate

Timeline

Start
2007-12
Primary completion
2008-08
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Oxybate Unknown

Indications